David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 47,592 shares at $22.02 ($1.1M) on 2011-03-16, disclosed to the SEC on 2011-03-17.
Scheduled sale ($1.1M) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.08 | 45,492 | $1.0M | 95.6% |
| 2 | $22.02 | 2,100 | $46K | 4.4% |
| Total | $22.08 avg | 47,592 | $1.1M | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |